View Older Stories View More Recent Stories

Jan 20, 2017 07:00AM Actinium Announces Participation in Three Upcoming Hematology Events
Jan 18, 2017 08:00AM Actinium Strengthens Executive Team and Enhances Clinical Development Capabilities with the Appointment of Dr. Mark Berger as Chief Medical Officer
Jan 10, 2017 07:00AM Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference 
Jan 4, 2017 07:00AM Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference
Dec 19, 2016 07:00AM Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical Programs
Dec 13, 2016 07:05AM Actinium Pharma (ATNM) Submits EU Orphan Designation Application for Actimab-A
Dec 13, 2016 07:00AM Actinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-A
Dec 12, 2016 07:00AM Actinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML
Dec 5, 2016 09:00PM Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting
Feb 6, 2015 01:25PM Unusual 11 Mid-Day Movers 2/6: (XLS) (ATV) (CBM) Higher; (RENT) (NKA) (ATNM) Lower
View More Recent Stories View Older Stories